Many people with major depressive disorder experience partial response to treatment: they improve, but don’t feel fully well, and may be at higher risk of relapse. If standard antidepressants aren’t enough, two emerging options worth discussing with your doctor are transcranial magnetic stimulation (TMS) and ketamine-based therapies. These treatments work differently from conventional medication, offering a potential path to more complete symptom relief.
Understanding Partial Response and Why It Matters
A partial response means you’re seeing some benefit from your current treatment, but residual symptoms remain. This isn’t just about feeling slightly down; even minor lingering depression can increase the chance of future depressive episodes. The goal isn’t just to feel better, but to achieve remission—a state where symptoms are minimal or absent. That’s why exploring more intensive options may be necessary.
Transcranial Magnetic Stimulation (TMS): Rewiring the Brain
TMS is a non-invasive procedure that uses magnetic pulses to stimulate specific areas of the brain involved in mood regulation, particularly the dorsolateral prefrontal cortex. This region is linked to negative thought patterns, and TMS aims to disrupt them.
- How it works: A cap fitted with a magnetic coil delivers pulses through the skull, inducing electrical activity. Sessions typically last 3–30 minutes, five days a week for at least a month.
- Side effects: Generally well-tolerated, but can include headache, facial twitching, ringing in the ears, and, rarely, seizures.
- Who benefits: TMS is often considered after one or two antidepressants have failed, or when side effects from medication are intolerable.
Ketamine and Esketamine: A Different Approach to Neurochemistry
Traditional antidepressants manipulate serotonin, dopamine, and norepinephrine. Ketamine, originally an anesthetic, works differently by blocking a neurotransmitter called N-methyl-D-aspartate (NMDA), which regulates glutamate—a key chemical in depression.
- How it works: Ketamine increases synaptic plasticity, essentially helping the brain form new connections rapidly. This can be particularly helpful for those who haven’t responded to other treatments.
- Delivery: Ketamine is administered through an IV infusion, while esketamine (Spravato) is an FDA-approved nasal spray taken under medical supervision.
- Side effects: Potential risks include high blood pressure, sleepiness, fainting, and dissociation (feeling detached from reality).
Insurance and Cost: A Major Barrier
Both TMS and ketamine therapies can be expensive, and insurance coverage varies widely. Many insurers require extensive documentation of failed prior treatments before approving these options. Generic ketamine is often cheaper but still an out-of-pocket expense when used off-label.
Talking to Your Doctor: What to Ask
If you’re considering TMS or ketamine, a thorough discussion with your healthcare provider is crucial.
- Clarify treatment effectiveness: Understand how well these options align with your specific symptoms.
- Explore alternatives: Don’t limit yourself; consider dosage adjustments, combination therapies, psychotherapy, and lifestyle changes.
- Ask why prior treatments failed: Identifying the root cause can help prevent future setbacks.
Bridging the gap between partial response and remission requires effort. Knowing your options and having an open conversation with your doctor can put you back in control of your mental health journey.
Ultimately, if standard antidepressants aren’t enough, TMS and ketamine provide additional pathways toward relief—but access can be challenging, and careful consideration is essential.
